Year: 2013
Type: editorial
Abstract: that control cell division require activation (T) loop phosphorylation for full activity. In metazoans, the only known CDK-activating kinase (CAK) is the Cdk7 complex, which was discovered ~20 y ago and subsequently implicated in CDK acti-vation in vivo in flies and worms. Cdk7 has another essential function as part of transcription factor IIH, to phosphorylate RNA polymerase (RNAP) II and other transcription factors. These two seem-ingly disparate roles, and the existence of divergent, non-cyclin-dependent CAKs in yeast, initially raised doubts about whether Cdk7 is a CAK in vivo, but no other metazoan enzyme capable of activat-ing CDKs has been identified.1 Conclusive evidence that human Cdk7 is a bona fide CAK emerged from chemical genetics—expanding the ATP binding pocket to accommodate bulky adenine analogs that inhibit the resulting analog-sensitive (AS) Cdk7, but not any wild-type kinase. Selective inhibition of Cdk7, in HCT116 colon cancer cells in which wild-type Cdk7 was replaced with Cdk7as, blocked activation of Cdk1 and Cdk2 and caused arrest at both G
Source: Cell Cycle
DOI: 10.4161/cc.26355
Authors: Miriam Merzel Schachter, Robert P Fisher
Institution: Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2045673429
